The company is a supplier of non-pharmaceutical rehabilitation products and medical devices for veterinary surgeries. The business combines the reputation of its products with clinical expertise to deliver several benefits for its clients, including increased efficiency and improved animal welfare.
Products include a market-leading range of laser devices used to treat a variety of conditions in horses and small animals, for which the company is the UK and Ireland distributor. This is offered alongside other surgical and non-surgical devices, an own-brand range of supplements designed to manage a number of common complaints, and regenerative medicines.
The shareholders are offering the company for sale as they wish to realise the assured wealth derived from the value of the existing business while facilitating further growth.
Offers invited.
Key Highlights
Supplies products to 640+ veterinary practices, veterinary suppliers and animal physiotherapists across the UK and Ireland, including corporate veterinary companies.
Around 80% of clients provide repeat business, with some relationships spanning 14 years.
Devices generate ongoing revenue from sales of consumables and services, bolstering repeat business from the supplements and regenerative medicines.
New products in its core range are due to be released in 2026, creating upselling opportunities within its existing client base.
Experienced team in place to manage day-to-day operations.
Operates from leasehold premises.
Financial Highlights
Generated a turnover of £1.55m in YE24, with an adjusted EBITDA of £240k.
Management turnover of £1.45 in YE25. Partial management turnover of £792k in the five months of YE26.
